Penn medicine researchers recently conducted the first-ever human CRISPR trial in the United States in Mar. 2019 to treat two cancer patients.
Penn medicine researchers recently conducted the first-ever human CRISPR trial in the United States in Mar. 2019 to treat two cancer patients.